US Broker Ratings

Roivant Sciences Ltd. (ROIV): Investor Outlook Reveals 47% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a UK-based biotechnology company, is capturing investor attention with its promising pipeline and substantial market potential. As a clinical-stage biopharmaceutical company, Roivant focuses on developing..

Centene Corporation (CNC) Investor Outlook: Unpacking a Potential 41.69% Upside

Centene Corporation (NYSE: CNC), a major player in the healthcare plans industry, continues to capture investor attention with its growth potential and diverse service offerings. As the healthcare landscape evolves,..

Genmab A/S (GMAB) Stock Analysis: A Danish Biotech Powerhouse with 44.82% Potential Upside

For investors seeking growth opportunities in the healthcare sector, Genmab A/S (GMAB) offers a compelling prospect. As a leading biotechnology firm based in Denmark, Genmab is making significant strides in..

ICON plc (ICLR) Stock Analysis: Unpacking the 21.20% Potential Upside

Investors searching for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing prospect. As a prominent player in the diagnostics and research industry, ICON plc has..

Repligen Corporation (RGEN) Investor Outlook: A 46.73% Upside Potential in Bioprocessing Technologies

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in developing cutting-edge bioprocessing technologies that cater to the life sciences industry. With a market capitalization of $6.94..

Natera, Inc. (NTRA) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 14.78% Upside Potential

Natera, Inc. (NTRA), a prominent player in the healthcare sector, particularly in diagnostics and research, offers investors a compelling growth narrative. With a market capitalization of $22.93 billion, this U.S.-based..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 88% Upside Potential

Investors seeking opportunities in the biotechnology sector should turn their attention to Corcept Therapeutics Incorporated (CORT), a dynamic player in the healthcare industry. With its focus on developing medications for..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 4.94% Potential Upside

For investors eyeing the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity with its solid footing in the diagnostics and research industry. Headquartered in Venlo, the Netherlands, Qiagen..

STERIS plc (STE) Investor Outlook: 10.18% Potential Upside in Healthcare Sector

For investors eyeing opportunities in the healthcare sector, STERIS plc (STE) presents a compelling case. With a market capitalization of $23.49 billion, STERIS operates in the medical devices industry, providing..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a Potential 20.75% Upside in the Healthcare Sector

Glaukos Corporation (NYSE: GKOS), a leading entity in the healthcare sector, presents a compelling case for investors interested in the medical devices industry. Headquartered in Aliso Viejo, California, Glaukos is..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Growth with a 22.5% ROE in the Healthcare Sector

Doximity, Inc. (DOCS), a leading digital platform for medical professionals, is making waves in the healthcare sector. With a market capitalization of $11.47 billion, the company offers a robust platform..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: An Investor’s Guide to Navigating a Strong Revenue Growth and Strategic Positioning

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, is an Indian multinational that has carved out a significant niche in the healthcare sector, specifically..

Solventum Corporation (SOLV) Stock Analysis: Healthcare Innovator with an 8.89% Upside Potential

Solventum Corporation (SOLV), a dynamic player in the healthcare sector, has been making waves with its innovative solutions across multiple segments. With a market capitalization of $13.06 billion, this U.S.-based..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Strong Buy Ratings and 31.87% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is gaining attention in the biotechnology sector with its innovative approach to developing treatments for genetic diseases and cancers. With a market capitalization of $8.52..

The Ensign Group, Inc. (ENSG) Investor Outlook: Growth Potential with 7.71% Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a significant player in the healthcare sector, specifically within the medical care facilities industry. As a well-established provider of skilled nursing, senior living,..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 21.11% Potential Upside in the Healthcare Tech Space

Waystar Holding Corp. (NASDAQ: WAY) is emerging as a compelling player in the healthcare information services industry, offering a suite of cloud-based solutions designed to streamline healthcare payments. With a..

Verona Pharma plc (VRNA) Stock Analysis: A Biotech with a Promising 21.51% Upside Potential

Investors with a keen eye on biotechnology stocks may find Verona Pharma plc (NASDAQ: VRNA) an intriguing prospect. As a leader in developing treatments for respiratory diseases, the UK-based company..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant Poised for Continued Growth

McKesson Corporation (NYSE: MCK) stands as a formidable entity in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $90.65 billion, McKesson is a titan..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and Promising Growth Potential in Biotechnology

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is capturing investor interest with its focused approach on developing therapies for serious and rare diseases. Headquartered in Bridgewater,..

DexCom, Inc. (DXCM) Stock Analysis: 14.20% Potential Upside Beckons Investors

In the dynamic landscape of medical devices, DexCom, Inc. (DXCM) stands out as a pioneering force in the field of continuous glucose monitoring (CGM) systems. With a robust market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds